SCHEDULE
14A INFORMATION
PROXY
STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF
1934
(AMENDMENT
NO. _____)
Filed by
the Registrant [ x ]
Filed by
a Party other than the Registrant [ ]
Check the
appropriate box:
[
] Preliminary Proxy Statement
[ ]
Confidential, for Use of the Commission. Only (as permitted by Rule
14a-6(e)(2))
[
] Definitive Proxy Statement
[X ]
Definitive Additional Materials
[ ]
Soliciting Material Pursuant to Rule 14a-12
DOR
BioPharma, Inc.
(Name of
Registrant as Specified in Its Charter)
N/A
(Name of
Person(s) Filing Proxy Statement if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
[ x ]
No fee required.
[ ]
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and
0-11.
(1) Title
of each class of securities to which transaction applies:
(2)
Aggregate number of securities to which transaction applies:
|
|
(3)
Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is
calculated and state how it was
determined):
|
|
|
(4)
Proposed maximum aggregate value of
transaction:
|
|
|
|
|
|
(5)
Total fee paid:
|
[ ]
Fee paid previously with preliminary materials.
[ ]
Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the form or schedule and the date of its filing.
(1)
Amount Previously Paid:
(2) Form,
Schedule or Registration Statement No.:
(3)
Filing Party:
(4) Date
Filed:
DOR
BIOPHARMA, INC.
29
Emmons Drive, Suite C-10
Princeton,
New Jersey 08540
NOTICE
OF INTERNET AVAILABILITY OF PROXY MATERIALS
To the
Stockholders:
The
Annual Meeting of Stockholders of DOR BioPharma, Inc. will be held at the
Wyndham Princeton Forrestal Hotel and Conference Center, Meeting Room:
Witherspoon C, 900 Scudders Mill Road, Plainsboro, New Jersey 08536, on June 4,
2009, at 10:00 a.m., Eastern Daylight Time, for the following purposes, each as
more fully described in the proxy statement for the Annual Meeting of
Stockholders:
1. To elect
five directors to serve until the next Annual Meeting of Stockholders or until
their respective successors have been duly elected and qualified;
2. To
consider and approve an amendment to our Amended and Restated Certificate of
Incorporation, as amended, to increase the number of authorized shares of our
common stock from 250,000,000 to 400,000,000;
3. To ratify
the appointment Amper, Politziner & Mattia, LLP as our independent auditors
for the year ending December 31, 2009; and
4. To
transact such other business as may properly come before the Annual Meeting or
any adjournment or postponement thereof.
Stockholders may access the Notice of
Annual Meeting of Stockholders, the Proxy Statement for Annual Meeting of
Stockholders, the Proxy and the Annual Report on Form 10-K for the fiscal year
ended December 31, 2008 at proxy.dorbiopharma.com
Important
notice regarding the availability of proxy materials for the stockholder meeting
to be held on June 4, 2009.
|
·
|
This
communication presents only an overview of the more complete proxy
materials that are available to you on the Internet. We
encourage you to access and review all of the important information
contained in the proxy materials before
voting.
|
|
·
|
The
proxy statement and annual report to security holders are available at
proxy.dorbiopharma.com.
|
|
·
|
If
you want to receive a paper or e-mail copy of these documents, you must
request one. There is no charge to you for requesting a
copy. Please make your request for a copy as instructed below
on or before May 21, 2009 to facilitate timely
delivery.
|
Stockholders
may request paper copies of the proxy materials, for all meetings and for the
particular meeting to which this Notice relates and obtain directions to be able
to attend the Annual Meeting and vote in person, or vote via Internet,
telephone or e-mail as more fully described below:
|
·
|
By
Internet: Go to proxy.dorbiopharma.com and follow the
instructions.
|
|
·
|
By
Telephone: Call 1-866-668-8562
|
|
·
|
By E-Mail: Email info@amstock.com
|
By Order
of the Board of Directors
/s/ Christopher J.
Schaber
Christopher
J. Schaber, Ph.D.
President
and Chief Executive Officer
Princeton,
New Jersey
April 24,
2009